Interestingly, endogenous TRAIL-R2 has recently been shown to promote proliferation of pancreatic cancer cells, in a ligand-independent manner, via inhibiting the processing of let-7 miRNA [177]. The gene discussed is TNFRSF10B; the disease is familial pancreatic carcinoma.